Evidence map›Paper›PMID 37156790›Full record

ArticleScientific reports2023

CoVnita, an end-to-end privacy-preserving framework for SARS-CoV-2 classification.

Jun Jie Sim, Weizhuang Zhou, Fook Mun Chan, Meenatchi Sundaram Muthu Selva Annamalai, Xiaoxia Deng, Benjamin Hong Meng Tan, Khin Mi Mi Aung

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun Jie SimInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore. simjj@i2r.a-star.edu.sg.
Weizhuang ZhouInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore.
Fook Mun ChanInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore.
Meenatchi Sundaram Muthu Selva AnnamalaiInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore.
Xiaoxia DengInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore.
Benjamin Hong Meng TanInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore.
Khin Mi Mi AungInstitute for Infocomm Research, Agency for Science, Technology And Research (A*STAR), Singapore, Singapore.
Institute for Infocomm Research · SGAgency for Science, Technology and Research · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classification of viral strains is essential in monitoring and managing the COVID-19 pandemic, but patient privacy and data security concerns often limit the extent of the open sharing of full viral genome sequencing data. We propose a framework called CoVnita, that supports private training of a classification model and secure inference with the same model. Using genomic sequences from eight common SARS-CoV-2 strains, we simulated scenarios where the data was distributed across multiple data providers. Our framework produces a private federated model, over 8 parties, with a classification AUROC of 0.99, given a privacy budget of [Formula: see text]. The roundtrip time, from encryption to decryption, took a total of 0.298 s, with an amortized time of 74.5 ms per sample.

Indexed as

COVID-19PrivacyComputer SecurityConfidentialityHumansPandemicsSARS-CoV-2

Identifiers

PMID37156790
PMCPMC10166033
OpenAlexW4375859272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.